Previous studies have demonstrated that CDK9 inhibition was particularly efficacious for HCC treatment with high myc expression because myc may require CDK9 to promote the expression of its downstream targets [22,23]. This evidence concerns the gene CDK9 and hepatocellular carcinoma.